Relative myotoxic and haemodynamic effects of the β-agonists fenoterol and clenbuterol measured in conscious unrestrained rats

Experimental Physiology

Volumn 91, Issue 6, 2006, Pages 1041-1049

  Burniston, Jatin G ^a   Tan, Lip Bun ^b   Goldspink, David F ^a  

^a LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BISOPROLOL; CASPASE 3; CLENBUTEROL; FENOTEROL; ISOPRENALINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOTOXICITY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; HEART MUSCLE; HEMODYNAMICS; HYPOTENSION; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; RAT; SOLEUS MUSCLE; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; TELEMETRY;

EID: 33750623980     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2006.035014     Document Type: Article

References (38)

1. Ahmet I, Krawczyk M, Heller P, Moon C, Lakatta EG & Talan MI (2004). Beneficial effects of chronic pharmacological manipulation of β-adrenoreceptor subtype signaling in rodent dilated ischemic cardiomyopathy. Circulation 110, 1083-1090.
2. 1-adrenoceptor density. Int J Cardiol 72, 137-141.
3. Beasley R, Pearce N, Crane J & Burgess C (1999). β-Agonists: what is the evidence that their use increases the risk of asthma morbidity and mortality? J Allergy Clin Immunol 104, S18-S30.
4. 2 receptor selectivity: a study of metaproterenol, fenoterol, isoproterenol, and epinephrine in patients with asthma. Am Rev Respir Dis 143, 444-446.
5. 2-adrenergic receptor agonist, clenbuterol. Muscle Nerve 32, 767-774.
6. 2- adrenergic receptor agonist clenbuterol in rat striated muscles. Muscle Nerve 33, 655-663.
7. Burniston JG, Ellison GM, Clark WA, Goldspink DF & Tan L-B (2005b). Relative toxicity of cardiotonic agents: some induce more cardiac and skeletal myocyte apoptosis and necrosis in vivo than others. Cardiovasc Toxicol 5, 355-364.
8. Burniston JG, Ng Y, Clark WA, Colyer J, Tan L-B & Goldspink DF (2002). Myotoxic effects of clenbuterol in the rat heart and soleus muscle. J Appl Physiol 93, 1824-1832.
9. Burniston JG, Saini A, Tan L-B & Goldspink DF (2005c). Aldosterone induces apoptosis in the heart and skeletal muscles of normotensive rats in vivo. JMol Cell Cardiol 39, 395-399.
10. Burniston JG, Saini A, Tan L-B & Goldspink DF (2005d). Angiotensin II induces apoptosis in vivo in skeletal, as well as cardiac, muscle of the rat. Exp Physiol 90, 755-761.
11. 2- Adrenergic receptor stimulation in vivo induces apoptosis in the rat heart and soleus muscle. J Appl Physiol 98, 1379-1386.
12. Communal C & Colucci WS (2005). The control of cardiomyocyte apoptosis via the β-adrenergic signaling pathways. Arch Mal Coeur Vaiss 98, 236-241.
13. 2-adrenergic receptors on cardiac myocyte apoptosis. Circulation 100, 1210-1217.
14. Communal C, Singha K, Pimentel DR & Colucci WS (1998). Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the β-adrenergic pathway. Circulation 98, 1329-1334.
15. De Angelis N, Fiordaliso F, Latini R, Calvillo L, Funicello M, Gobbi M, Mennini T & Masson S (2002). Appraisal of the role of angiotensin II and aldosterone in ventricular myocyte apoptosis in adult normotensive rat. J Mol Cell Cardiol 34, 1655-1665.
16. Duchanie D (1992). Underground Steroid Handbook (II) Update: 1992. HLR Technical Books, Venice, CA, USA.
17. 1-adrenergic receptor transgenic mice. Pharmacology 96, 7059-7064.
18. Goldspink DF, Burniston JG, Ellison GM, Clark WA & Tan LB (2004). Catecholamine-induced apoptosis and necrosis in cardiac and skeletal myocytes of the rat in vivo: the same or separate death pathways? Exp Physiol 89, 407-416.
19. Goldstein DR, Dobbs T, Krull B & Plumb VJ (1998). Clenbuterol and anabolic steroids: a previously unreported cause of myocardial infarction with normal coronary arteriograms. South Med J 91, 780-784.
20. Hoffmann C, Leitz MR, Oberdorf-Maass S, Lohse MJ & Klotz KN (2004). Comparative pharmacology of human β-adrenergic receptor subtypes - characterization of stably transfected receptors in CHO cells. Naunyn Schmiedebergs Arch Pharmacol 369, 151-159.
21. Hon JK & Yacoub MH (2003). Bridge to recovery with the use of left ventricular assist device and clenbuterol. Ann Thorac Surg 75, S36-S41.
22. 2-Adrenergic receptor desensitization, internalization, and phosphorylation in response to full and partial agonists. J Biol Chem 272, 23871-23879.
23. 2-adrenoceptor agonist prodrug BRL-47672 on cardiovascular function, skeletal muscle myosin heavy chain, and MyoD expression in the rat. J Pharmacol Exp Ther 311, 1225-1231.
24. Kierzkowska B, Stanczyk J & Kasprzak JD (2005). Myocardial infarction in a 17-year-old body builder using clenbuterol. Circ J 69, 1144-1146.
25. 2-adrenergic receptor overexpression in mouse hearts: critical role for expression level. Circulation 101, 1707-1714.
26. Mann DL, Kent RL, Parsons B & Cooper G (1992). Adrenergic effects on the biology of the adult mammalian cardiomyocyte. Circulation 85, 790-804.
27. Ng Y, Goldspink DF, Burniston JG, Clark WA, Colyer J & Tan L-B (2002). Characterisation of isoprenaline myotoxicity on slow-twitch versus cardiac muscle. Int J Cardiol 86, 299-309.
28. Pack RJ, Alley MR, Dallimore JA, Wood KR, Burgess C & Crane J (1994). The myocardial effects of fenoterol, isoprenaline and salbutamol in normoxic and hypoxic sheep. Int J Exp Pathol 75, 357-362.
29. Rajab P, Fox J, Riaz S, Tomlinson D, Ball D & Greenhaff PL (2000). Skeletal muscle myosin heavy chain isoforms and energy metabolism after clenbuterol treatment in the rat. Am J Physiol Regul Integr Comp Physiol 279, R1076-R1081.
30. 2-Agonist fenoterol has greater effects on contractile function of rat skeletal muscles than clenbuterol. Am J Physiol Regul Integr Comp Physiol 283, R1386-R1394.
31. 2-agonist controversy. Observations, explanations and relationship to asthma epidemiology. Drug Saf 11, 259-283.
32. 2-adrenoceptors, and adenylyl cyclase activation in female rats. Am J Physiol 268, E159-E167.
33. Soppa GK, Smolenski RT, Latif N, Yuen AH, Malik A, Karbowska J, Kochan Z, Terracciano CM & Yacoub MH (2005). Effects of chronic administration of clenbuterol on function and metabolism of adult rat cardiac muscle. Am J Physiol Heart Circ Physiol 288, H1468-H1476.
34. Tan L-B, Burniston JG, Clark WA, Ng Y & Goldspink DF (2003). Characterisation of adrenoceptor involvement in skeletal and cardiac myotoxicity induced by sympathomimetic agents: towards a new bioassay for β-blockers. J Cardiovasc Pharmacol 41, 518-525.
35. 1-AR- mediated positive inotropic effect in myocytes from failing rat hearts. Circulation 108, 1633-1639.
36. 2- Adrenergic stimulation attenuates left ventricular remodeling, decreases apoptosis, and improves calcium homeostasis in a rodent model of ischemic cardiomyopathy. J Pharmacol Exp Ther 317, 553-561.
37. Yacoub MH (2001). A novel strategy to maximise the efficacy of left ventricular assist devices as a bridge to recovery. Eur Heart J 22, 534-540.
38. Zaugg M, Xu W, Lucchinetti E, Shaiq SA, Jamali NZ & Siddiqui MAQ (2000). β-Adrenergic receptor subtypes differentially affect apoptosis in adult rat ventricular myocytes. Circulation 102, 344-350.